US Map / Massachusetts
State MA

Clinical Trials in Massachusetts

Massachusetts is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Massachusetts and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Massachusetts sites out of 474 registered in total. The busiest research areas in Massachusetts are Prostate Cancer, Colorectal Cancer, Breast Cancer. Leading sponsors running trials in the state include Massachusetts General Hospital, Brigham and Women's Hospital, Boston Children's Hospital. By stage, Massachusetts trials break down as Phase 1 (86), Phase 2 (125), Phase 3 (78), Phase 4 (14).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Massachusetts
Prostate Cancer (8)Colorectal Cancer (7)Breast Cancer (7)Cancer (6)Solid Tumor (6)Heart Failure (6)Lung Cancer (6)Advanced Solid Tumors (6)Multiple Myeloma (6)Schizophrenia (5)Acute Myeloid Leukemia (5)Healthy (5)

Frequently Asked Questions — Clinical Trials in Massachusetts

How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Colorectal Cancer, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Massachusetts

NCT04735835 N/A
Recruiting
Personalized Responses to Dietary Composition Trial 3
Condition
Diabetes
Enrollment
250,000 pts
Location
United States, United Kingdom
Sponsor
Zoe Global Limited
View Trial →
NCT04188535 N/A
Recruiting
Serial MRI Scans During Radiation Therapy
Condition
Glioblastoma
Enrollment
149 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT04829617 N/A
Recruiting
Promoting Well-being and Health in Heart Failure
Condition
Heart Failure
Enrollment
280 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04128189 Phase 3
Recruiting
Shingrix in Renal Transplant Recipients
Condition
Kidney Transplant Recipient Response to Shingrix Vaccine
Enrollment
132 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07269210 Phase 2
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceride...
Condition
Severe Hypertriglyceridemia
Enrollment
60 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
View Trial →
NCT05646576 N/A
Recruiting
Defining the Role of Palliative carE for Patients With Hematologic Malignancies ...
Condition
Hematologic Malignancy
Enrollment
90 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06726148 Phase 1, Phase 2
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER...
Condition
Advanced HR+/HER2- Breast Cancer
Enrollment
280 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05443126 Phase 1, Phase 2
Recruiting
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancie...
Condition
NSCLC
Enrollment
265 pts
Location
United States, France, Germany
Sponsor
Ellipses Pharma
View Trial →
NCT07761026 N/A
Recruiting
AXIS MG Patient Registry
Condition
Myasthenia Gravis (MG)
Enrollment
1,000 pts
Location
United States
Sponsor
Autoimmune Neurology Alliance
View Trial →
NCT04652115 Phase 2
Recruiting
Defibrotide for the Treatment of Severe COVID-19
Condition
Covid19
Enrollment
42 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT02896348 N/A
Recruiting
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Han...
Condition
Stroke
Enrollment
40 pts
Location
United States
Sponsor
Spaulding Rehabilitation Hospi
View Trial →
NCT05674643 N/A
Recruiting
Gastric Assessment of Pediatric Patients Undergoing Surgery
Condition
Fasting
Enrollment
60 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06273176 N/A
Recruiting
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent...
Condition
Glioblastoma, IDH-wildtype
Enrollment
225 pts
Location
United States, Belgium, Germany
Sponsor
Erasmus Medical Center
View Trial →
NCT06553976 N/A
Recruiting
Spastic Paraplegia - Centers of Excellence Research Network
Condition
Hereditary Spastic Paraplegia
Enrollment
100 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06618040 N/A
Recruiting
Bedtime Stories: Tailored Sleep Health Messaging for Caregivers
Condition
Sleep
Enrollment
75 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT04372615 Phase 2
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Condition
Autoimmune Encephalitis
Enrollment
116 pts
Location
United States, Netherlands, Spain
Sponsor
University of Utah
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT07033208 N/A
Recruiting
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal T...
Condition
Crohn Disease
Enrollment
25 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07118358 N/A
Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Condition
Leadless Pacemaker
Enrollment
325 pts
Location
United States, Australia, Austria
Sponsor
Biotronik, Inc.
View Trial →
NCT07710443 N/A
Recruiting
Safety and Effectiveness of Mosaic for the Treatment of Midface Volume Deficit
Condition
Midface Volume Deficit
Enrollment
50 pts
Location
United States
Sponsor
Helios Aesthetics Inc.
View Trial →
NCT06119243 N/A
Recruiting
Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
Condition
Myopia
Enrollment
230 pts
Location
United States, Australia
Sponsor
The University of New South Wa
View Trial →
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05224414 N/A
Recruiting
Interpretation Bias as a Mechanism of Treatment Response in OCD
Condition
Obsessive-Compulsive Disorder
Enrollment
106 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →
NCT06118723 N/A
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Gra...
Condition
Glioblastoma
Enrollment
784 pts
Location
United States, Belgium, Germany
Sponsor
Jasper Gerritsen
View Trial →
NCT01799915 N/A
Recruiting
Natural History Study of Synucleinopathies
Condition
Patients With Synucleinopathies
Enrollment
800 pts
Location
United States, Argentina, South Korea
Sponsor
NYU Langone Health
View Trial →
Page 5 of 19 — 474 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology